Export 364 results:
Sort by: [ Author  (Asc)] Title Type Year
A B C D E F G H I J K L M N O [P] Q R S T U V W X Y Z   [Show ALL]
Psychalinos, C., A. S. Elwakil, A. G. Radwan, and K. Biswas, "Guest editorial: fractional-order circuits and systems: theory, design, and applications", Circuits, Systems, and Signal Processing, vol. 35, no. 6: Springer US, pp. 1807–1813, 2016. Abstract
Psychalinos, C., A. S. Elwakil, A. G. Radwan, and K. Biswas, "Guest editorial: fractional-order circuits and systems: theory, design, and applications", Circuits, Systems, and Signal Processing, vol. 35: Springer US, pp. 1807–1813, 2016. Abstract
PTD, E. S. M. F., E. E. PTD, and W. T. PTD, "Assessment of Postural Stability in Patients with Low Back Pain", Bull. Fac. Ph. Th. Cairo Univ, vol. 15, no. 1, pp. 1, 2010. Abstract
de la Puente, P., N. Quan, R. S. Hoo, B. Muz, R. C. Gilson, M. Luderer, J. King, S. Achilefu, N. N. Salama, R. Vij, et al., "Newly established myeloma-derived stromal cell line MSP-1 supports multiple myeloma proliferation, migration, and adhesion and induces drug resistance more than normal-derived stroma.", Haematologica, vol. 101, issue 7, pp. e307-11, 2016 Jul. salama-_haematologica_2016.pdf
de la Puente, P., M. J. Luderer, C. Federico, A. Jin, R. C. Gilson, C. Egbulefu, K. Alhallak, S. Shah, B. Muz, J. Sun, et al., "Enhancing proteasome-inhibitory activity and specificity of bortezomib by CD38 targeted nanoparticles in multiple myeloma.", Journal of controlled release : official journal of the Controlled Release Society, vol. 270, pp. 158-176, 2017 Nov 28, 2018. Abstractj_of_controlled_release_2018.pdf

The establishment of more effective treatments that can circumvent chemoresistance in Multiple Myeloma (MM) is a priority. Although bortezomib (BTZ) is one of the most potent proteasome inhibitors available, still possesses limitations related to dose limiting side effects. Several strategies have been developed to improve the delivery of chemotherapies to MM by targeting different moieties expressed on MM cells to nanoparticle delivery systems (NPs), which have failed mainly due to their heterogeneous expression on these cells. Our goal was to test CD38 targeted chitosan NPs as novel targeting moiety for MM to improve the potency and efficacy of BTZ in MM cells and reduce the side effects in healthy tissue. We have showed preferential BTZ release in tumor-microenvironment, specific binding to MM cells, and an improved drug cellular uptake through BTZ diffusion from the surface and endocytosed NPs, which translated in enhanced proteasome inhibition and robust cytotoxic effect on MM cells when BTZ was administered through anti-CD38 chitosan NPs. Furthermore, the anti-CD38 chitosan NPs specifically delivered therapeutic agents to MM cells improving therapeutic efficacy and reducing side effects in vivo. The anti-CD38 chitosan NPs showed low toxicity profile allowing enhancement of proteasome-inhibitory activity and specificity of BTZ by endocytosis-mediated uptake of CD38 representing a promising therapy in MM.

de la Puente, P., B. Muz, A. Jin, F. Azab, M. Luderer, N. N. Salama, and A. K. Azab, "MEK inhibitor, TAK-733 reduces proliferation, affects cell cycle and apoptosis, and synergizes with other targeted therapies in multiple myeloma.", Blood cancer journal, vol. 6, pp. e399, 2016 Feb 26. salama-_blood_cancer_j_2016.pdf
de la Puente, P., N. Fettig, M. J. Luderer, A. Jin, S. Shah, B. Muz, V. Kapoor, S. M. Goddu, N. N. Salama, C. Tsien, et al., "Injectable Hydrogels for Localized Chemotherapy and Radiotherapy in Brain Tumors.", Journal of pharmaceutical sciences, vol. 107, pp. 922-933, 2017 Nov 21, 2018. Abstractj_pharm_sci-_2018.pdf

Overall survival of patients with newly diagnosed glioblastoma (GBM) remains dismal at 16 months with state-of-the-art treatment that includes surgical resection, radiation, and chemotherapy. GBM tumors are highly heterogeneous, and mechanisms for overcoming tumor resistance have not yet fully been elucidated. An injectable chitosan hydrogel capable of releasing chemotherapy (temozolomide [TMZ]) while retaining radioactive isotopes agents (iodine, [131I]) was used as a vehicle for localized radiation and chemotherapy, within the surgical cavity. Release from hydrogels loaded with TMZ or 131I was characterized in vitro and in vivo and their efficacy on tumor progression and survival on GBM tumors was also measured. The in vitro release of 131I was negligible over 42 days, whereas the TMZ was completely released over the first 48 h. 131I was completely retained in the tumor bed with negligible distribution in other tissues and that when delivered locally, the chemotherapy accumulated in the tumor at 10-fold higher concentrations than when delivered systemically. We found that the tumors were significantly decreased, and survival was improved in both treatment groups compared to the control group. Novel injectable chemo-radio-hydrogel implants may potentially improve the local control and overall outcome of aggressive, poor prognosis brain tumors.

Puetz, M., M. Bohrer, S. Mai, M. Polednik, D. Wolff, Y. Abo-Madyan, F. Lohr, and F. Wenz, "Local control of the brain metastases after igSRS (image guided stereotactic radiosurgery) with the Sequential Tomotherapy (MIMiC)", STRAHLENTHERAPIE UND ONKOLOGIE, vol. 186: URBAN & VOGEL NEUMARKTER STRASSE 43, D-81673 MUNICH, GERMANY, pp. 116–116, 2010. Abstract
Pushpan, S. K., S. Venkatraman, V. G. Anand, J. Sankar, D. Parmeswaran, S. Ganesan, and T. K. Chandrashekar, "Porphyrins in photodynamic therapy-a search for ideal photosensitizers", Current Medicinal Chemistry-Anti-Cancer Agents, vol. 2, issue 2: Bentham Science Publishers, pp. 187-207, 2002. Abstract
Pusiol, A., F. Marzona, D. Cucchiaro, L. Castriotta, S. Usai, M. Narduzzi, C. Pilotto, I. Liguoro, R. Tosolini, and E. Passone, "Articles online first", Minerva Pediatrica, 2020. Abstract
Putman, M., K. Kennedy, E. Sirotich, J. W. Liew, S. E. Sattui, T. T. Moni, A. A. Akpabio, D. Alpizar-Rodriguez, S. Angevare, R. P. Beesley, et al., "COVID-19 vaccine perceptions and uptake: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey.", The Lancet. Rheumatology, vol. 4, issue 4, pp. e237-e240, 2022.
Płotka-Wasylka, J., M. - C. P, G. SZ, and H. M. Mohamed, "End-of-life management of single-use baby diapers: Analysis of technical, health and environment aspects.", Science of The Total Environment, vol. 836, pp. 155339, 2022.
Płotka-Wasylka, J., H. M. Mohamed, and A. Kurowska-Susdorf, "Green analytical chemistry as an integral part of sustainable education development", Current Opinion in Green and Sustainable Chemistry, vol. 31, pp. 100508-100514, 2021.